GoAI
Get started
CVS Health Corp. logo

CVS Health Corp.

CVS

NYSEHealthcareMedical - Healthcare Plans

Open in GoAI

Previous close

$93.02

−$0.63 · -0.67%

Aug 21, 4:00 PM ET

CVS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

53

Fair Value

Momentum

63

Gaining

Sentiment

61

Bullish

Risk resilience

85

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Industry
Medical - Healthcare Plans
Sector
Healthcare
Headquarters
US
CEO
J. David Joyner
Listed since
Feb 21, 1973
Employees
259,500

Market position

Day range

Current $93.02

52-week range

Current $93.02

Open
$94.21
Previous close
$93.65
Volume
5.59M
0.68× average
Average volume
8.24M
Average daily volume
Market cap
118.69B USD
Beta
0.6
Market reference 1
50-day average
$102.01
-8.81% below average
200-day average
$85.7402
+8.49% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
185.63B USD
EV / EBITDA
18.82×
Earnings yield
1.76%
Free cash flow yield
7.76%

Profitability & efficiency

Return on equity
2.35%
Return on assets
0.68%
Return on invested capital
4.72%

Financial health

Current ratio
0.84×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends20%13%6%-1%Gross margin, FY2021: 17.84%Gross margin, FY2022: 16.90%Gross margin, FY2023: 15.21%Gross margin, FY2024: 13.79%Gross margin, FY2025: 13.77%Operating margin, FY2021: 4.56%Operating margin, FY2022: 2.47%Operating margin, FY2023: 3.84%Operating margin, FY2024: 2.28%Operating margin, FY2025: 2.58%Net margin, FY2021: 2.74%Net margin, FY2022: 1.34%Net margin, FY2023: 2.33%Net margin, FY2024: 1.24%Net margin, FY2025: 0.44%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 17.84%. Gross margin FY2022 16.90%. Gross margin FY2023 15.21%. Gross margin FY2024 13.79%. Gross margin FY2025 13.77%. Operating margin FY2021 4.56%. Operating margin FY2022 2.47%. Operating margin FY2023 3.84%. Operating margin FY2024 2.28%. Operating margin FY2025 2.58%. Net margin FY2021 2.74%. Net margin FY2022 1.34%. Net margin FY2023 2.33%. Net margin FY2024 1.24%. Net margin FY2025 0.44%.

Income trends

Revenue

402.07B USD+7.85%

Operating income

10.39B USD+21.95%

Net income

1.77B USD-61.68%
Income trends across reported periods442.1B USD281.98B USD121.86B USD−38.26B USDRevenue, FY2021: 292.11B USDRevenue, FY2022: 322.47B USDRevenue, FY2023: 357.78B USDRevenue, FY2024: 372.81B USDRevenue, FY2025: 402.07B USDOperating income, FY2021: 13.31B USDOperating income, FY2022: 7.95B USDOperating income, FY2023: 13.74B USDOperating income, FY2024: 8.52B USDOperating income, FY2025: 10.39B USDNet income, FY2021: 8B USDNet income, FY2022: 4.31B USDNet income, FY2023: 8.34B USDNet income, FY2024: 4.61B USDNet income, FY2025: 1.77B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 292.11B USD. Revenue FY2022 322.47B USD. Revenue FY2023 357.78B USD. Revenue FY2024 372.81B USD. Revenue FY2025 402.07B USD. Operating income FY2021 13.31B USD. Operating income FY2022 7.95B USD. Operating income FY2023 13.74B USD. Operating income FY2024 8.52B USD. Operating income FY2025 10.39B USD. Net income FY2021 8B USD. Net income FY2022 4.31B USD. Net income FY2023 8.34B USD. Net income FY2024 4.61B USD. Net income FY2025 1.77B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue402.07B USD372.81B USD357.78B USD322.47B USD292.11B USD
Cost of goods sold346.71B USD321.41B USD303.35B USD267.97B USD239.99B USD
Gross profit55.36B USD51.4B USD54.43B USD54.5B USD52.12B USD
Selling, general, and administrative—41.23B USD———
Operating expenses44.98B USD42.89B USD40.69B USD46.55B USD38.81B USD
Interest expense3.12B USD2.96B USD2.66B USD2.29B USD2.5B USD
Depreciation and amortization4.61B USD4.6B USD4.37B USD4.22B USD4.49B USD
Operating income10.39B USD8.52B USD13.74B USD7.95B USD13.31B USD
Net income1.77B USD4.61B USD8.34B USD4.31B USD8B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 2 misses, 0 met estimates
Average EPS surprise
+11.87%
11 comparable reports
Latest EPS result
2.58
Estimate 1.87 · Beat by 37.97%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.712.071.420.78Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 1.19, estimate 0.914, surprise +30.20%, Beat. Q2 2025, reported May 1, 2025: actual 2.25, estimate 1.7, surprise +32.35%, Beat. Q3 2025, reported Jul 31, 2025: actual 1.81, estimate 1.46, surprise +23.97%, Beat. Q4 2025, reported Oct 29, 2025: actual 1.6, estimate 1.37, surprise +16.79%, Beat. Q1 2026, reported Feb 10, 2026: actual 1.09, estimate 1, surprise +9.00%, Beat. Q2 2026, reported May 6, 2026: actual 2.57, estimate 2.21, surprise +16.29%, Beat. Q3 2026, reported Aug 5, 2026: actual 2.58, estimate 1.87, surprise +37.97%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 1.63, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates110.34B103.37B96.4B89.43BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 12, 2025: actual 97.71B USD, estimate 97.09B USD, surprise +0.64%, Beat. Q2 2025, reported May 1, 2025: actual 94.59B USD, estimate 93.68B USD, surprise +0.97%, Beat. Q3 2025, reported Jul 31, 2025: actual 98.92B USD, estimate 94.53B USD, surprise +4.64%, Beat. Q4 2025, reported Oct 29, 2025: actual 102.87B USD, estimate 98.81B USD, surprise +4.11%, Beat. Q1 2026, reported Feb 10, 2026: actual 105.69B USD, estimate 103.7B USD, surprise +1.92%, Beat. Q2 2026, reported May 6, 2026: actual 106.1B USD, estimate 94.99B USD, surprise +11.69%, Beat. Q3 2026, reported Aug 5, 2026: actual 106.1B USD, estimate 100.03B USD, surprise +6.07%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 104.21B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$110.47

18.76% upside
Past 12 months12-month forecastHigh $126Average $110.47Low $92.00

CVS peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding CVS

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
4.24B
Weight
0.18%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard S&P 500 ETF logoVanguard S&P 500 ETFVOO
Market value
3.5B
Weight
0.21%
AUM
1.7T USD
Expense ratio
0.03%
Price / 1D
$703.71+0.39%
iShares Core S&P 500 ETF logoiShares Core S&P 500 ETFIVV
Market value
1.61B
Weight
0.18%
AUM
891.84B USD
Expense ratio
0.03%
Price / 1D
$769.31+0.39%
State Street SPDR S&P 500 ETF logoState Street SPDR S&P 500 ETFSPY
Market value
1.48B
Weight
0.18%
AUM
817.87B USD
Expense ratio
0.09%
Price / 1D
$765.72+0.41%
Vanguard Morningstar Value ETF logoVanguard Morningstar Value ETFVTV
Market value
1.27B
Weight
0.49%
AUM
256.5B USD
Expense ratio
0.03%
Price / 1D
$226.4+0.54%
State Street Health Care Select Sector SPDR ETF logoState Street Health Care Select Sector SPDR ETFXLV
Market value
859.53M
Weight
1.92%
AUM
44.76B USD
Expense ratio
0.08%
Price / 1D
$174.62+1.29%
Vanguard High Dividend Yield ETF logoVanguard High Dividend Yield ETFVYM
Market value
539.73M
Weight
0.54%
AUM
99.2B USD
Expense ratio
0.04%
Price / 1D
$164.97+0.59%
Vanguard Health Care ETF logoVanguard Health Care ETFVHT
Market value
403.7M
Weight
1.93%
AUM
20.9B USD
Expense ratio
0.09%
Price / 1D
$327.7+1.24%

Continue in GoAI

Research CVS

research.disclaimer